Liabilities / Assets
86th percentile
Higher debt load relative to assets than 86% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
86th percentile
Higher debt load relative to assets than 86% of similar nonprofits.
Liabilities / Revenue
81st percentile
Higher debt load relative to revenue than 81% of similar nonprofits.
Net Margin
22nd percentile
Higher net margin than 22% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
76th percentile
Faster asset growth than 76% of similar nonprofits.
Revenue Growth
19th percentile
Faster revenue growth than 19% of similar nonprofits.
Assets
Up$472,032
Up $68,259 (+17%) from 2013
Net Assets
Down$168,796
Down $61,415 (-27%) from 2013
Liabilities
Up$303,236
Up $129,674 (+75%) from 2013
Revenue
Down$739,208
Down $115,019 (-13%) from 2013
Expenses
Down$800,623
Down $74,527 (-8.5%) from 2013
Net Income
Down-$61,415
Down $40,492 (-194%) from 2013
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
All activities for research and treatment of Cystic Fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.